12 reports

  • VY-OZ - DRUG PROFILE

Anakinra blocks the biologic activity of interleukin-## by competitively inhibiting interleukin-## binding to the interleukin-## type I receptor (IL ##RI), which is expressed in a wide variety of tissues and organs.

  • Cardiovascular Disease
  • Sweden
  • United States
  • World
  • Product Initiative
  • VY-OZ - DRUG PROFILE

Anakinra blocks the biologic activity of interleukin-## by competitively inhibiting interleukin-## binding to the interleukin-## type I receptor (IL ##RI), which is expressed in a wide variety of tissues and organs.

  • Cardiovascular Disease
  • Pathology
  • World
  • Product Initiative
  • Evotec AG

MOREOVER, THERE CAN ALSO BE SIDE EFFECTS ARISING FROM ERRORS SUCH AS DISPLACED ELECTRODES, WHICH CAN LEAD TO STROKE, ENCEPHALITIS, OR INFECTION IN THE BRAIN.

  • Cardiovascular Disease
  • North America
  • United States
  • World
  • Market Size
  • POLYGLACTIN 370 FOR MYOCARDIAL INFARCTION - DRUG PROFILE
  • MYOCARDIAL INFARCTION - PIPELINE BY ATHERSYS INC, H1 2018

It provides vaccines and therapeutics for various infections such as Japanese encephalitis, diphtheria and others.

  • Cardiovascular Disease
  • Cell Therapy
  • United States
  • World
  • Product Initiative

ZYAN-## acts as PHD-## inhibitor.

  • Cardiovascular Disease
  • Chronic Pain
  • Healthcare
  • Infectious Disease
  • Cadila Healthcare Ltd

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Cardiovascular Disease
  • Clinical Trial
  • Healthcare
  • United States
  • GlobalData's company

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Cardiovascular Disease
  • Clinical Trial
  • Diagnostics
  • United States
  • GlobalData's company
  • POLYGLACTIN 370 FOR MYOCARDIAL INFARCTION - DRUG PROFILE
  • MYOCARDIAL INFARCTION - PIPELINE BY BHARAT BIOTECH INTERNATIONAL LTD, H2 2017

It provides vaccines and therapeutics for various infections such as Japanese encephalitis, diphtheria and others.

  • Cardiovascular Disease
  • Chronic Disease
  • United States
  • Product Initiative
  • Athersys, Inc.

Antiviral activity was also observed against other flaviviruses such as the yellow fever virus and the tick-borne encephalitis virus (TBEV).

  • Cardiovascular Disease
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States

BioFire Diagnostics, a bioMérieux company, received clearance from the FDA for the FilmArray Meningitis/ Encephalitis (ME) Panel.

  • Cardiovascular Disease
  • Diabetes
  • North America
  • United States
  • Roche Group

Partner ##: Amgen, Inc.

  • Cardiovascular Disease
  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • MedImmune, LLC
  • POLYGLACTIN 370 FOR ISCHEMIC STROKE - DRUG PROFILE

The company reported that the drug candidate has been FDA approved for orphan drug designation for the treatment of acute encephalitis syndrome.

  • Cardiovascular Disease
  • Neurological Disorder
  • United States
  • Company
  • Product Initiative